We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The best-selling drug in the world: Humira does not look good anymore. The assessment results of ICER, a cost-effectiveness watchdog, are that: Humira isn’t worth its current price.